News and Breakthroughs
Read the latest news from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The links below take you to articles where you can learn more about our center's latest events and accomplishments. You can also visit the article archive for older news. Visit our Photo Gallery to view photos and videos from various events
Patients, survivors, caregivers, and supporters recently joined expert breast cancer clinicians and scientists at Northwestern University Feinberg School of Medicine for a panel discussion about the latest breast cancer treatments, trends, and research.
A Northwestern Medicine study reports the first guidelines for treating sebaceous carcinoma, a cancer of the oil glands diagnosed in thousands of patients every year.
Northwestern Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University are proud to participate in the 2019 American Society of Hematology (ASH) Annual Meeting.
A new machine-learning tool demonstrates the clinical potential of ‘junk DNA’ methylation in hepatitis C-associated liver cancer patients without the need for expensive testing.
A new review has found that a combination of endocrine inhibitors and hormone therapy is more effective in prolonging progression-free survival for advanced breast cancer patients, as compared to chemotherapy.
Northwestern Medicine scientists have created a small molecule that reduces expression of MYC, a cancer-causing protein involved in a wide variety of cancers.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the University of Notre Dame are pleased to announce a collaboration designed to catalyze interdisciplinary translational research.
Lymphoma expert Jane Winter, MD, has been elected to the leadership of the American Society of Hematology (ASH). She will serve a one-year term as vice president, followed by successive terms as president-elect and president of ASH, the world’s largest professional society concerned with the causes and treatment of blood disorders.
The overexpression of mitochondrial superoxide dismutase, commonly found in late-stage tumors, may drive cancer stem cell formation and contribute to the failure of chemotherapy treatment in breast cancer patients.
Scientists co-led by Sui Huang, MD, PhD, found an experimental drug called metarrestin significantly reduced metastasis and cancer progression in mouse models.
Barbara Pro, MD, a leader in the research and treatment of lymphomas, has been named Clinical Director of the Lymphoma Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Pro is Professor of Medicine in the Division of Hematology and Oncology, and also serves as Director of the Hematology and Oncology Fellowship Program.
Northwestern and Cell Press hosted a symposium on transcriptional regulation, welcoming more than 350 attendees from around the world.
Timothy Pearman, PhD, Director of Supportive Oncology, discusses the inherent challenge for people affected by cancer.
Jyoti Patel, MD, will join Northwestern Medicine as Medical Director of Thoracic Oncology and Assistant Director for Clinical Research at the Lurie Cancer Center, effective November 1, 2019. She will also serve as Associate Vice Chair for Clinical Research in the Department of Medicine.
High levels of folate, a B vitamin, can force glial nerve cells to transform back into undifferentiated stem cells, according to a new study published in the journal Stem Cells.
A multi-institutional study led by Edward M. Schaeffer, MD, PhD, is the largest genomic analysis of prostate cancer to date, encompassing nearly 20,000 patients with localized prostate cancer.
A revolutionary new approach that analyzes a tiny sample of blood, can detect life-threatening vascular complications in diabetic patients earlier and more accurately than traditional tests.
- Vadim Backman Named Associate Director for Research Technology and Infrastructure at Lurie Cancer Center10.01.2019
Vadim Backman, PhD, has been named Associate Director for Research Technology and Infrastructure at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, effective October 1.
The first prostate cancer treatment based on the genetic makeup of the cancer resulted in significant improvements, according to a large international trial led by Northwestern Medicine investigators.
Hear Rimas Lukas, MD, discuss promising new clinical trials and other research underway to improve glioblastoma treatment.
See more news in the article archive.